This announcement is a separate document:
中源协和细胞基因工程股份有限公司独立董事关于收购参股子公司合源生物科技（天津）有限公司股东所持部分股权暨关联交易的独立意见
Independent opinions of the independent director of Zhongyuan Xiehe Cell Genetic Engineering Co., Ltd. on the acquisition of some shares held by shareholders of the participating subsidiary Heyuan Biotechnology (Tianjin) Co., Ltd. and related transactions
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated